GLP-1s & Eating Disorders: What to Say When Clients Ask

About
As the use of GLP-1 medications (e.g., Ozempic, Wegovy) rises, so do concerns about their prescription to individuals with active, historical, or at-risk eating disorders. This webinar supports ED practitioners in navigating complex, relational conversations with clients exploring or already using these medications.This is not a webinar on pharmacology or pathophysiology of GLP-1s. Rather, it focuses on relational, ethical, and consent-based approaches to client care.
Date
Thursday 3 July 2025 7:00 PM - 9:00 PM (UTC+10)Location
Online event access details will be provided by the event organiser